Skip to main content

Eating a Bowl of Yogurt May Help Reduce Your Risk of Depression

Researchers found that Lactobacillus – “friendly” bacteria present in live-cultured yogurt – reversed depressive-like behavior in mice by altering their gut microbiome, the population of microorganisms that reside in the intestines.
The study authors – from the University of Virginia School of Medicine – believe it is possible that the probiotic could do the same for humans. “The big hope for this kind of research is that we won’t need to bother with complex drugs and side effects when we can just play with the microbiome,” says lead researcher Alban Gaultier, Ph.D., of the Center for Brain Immunology and Glia at Virginia. “It would be magical just to change your diet, to change the bacteria you take, and fix your health – and your mood,” he adds. An increasing number of studies have indicated that the gut microbiome plays a significant role in mental health. Research published in 2014, for example, found that probiotics – which boost the abundance of friendly gut bacteria – reduced anxiety and stress in adults. Low Lactobacillus levels led to depression-like symptoms in mice For this latest study – publishedTrusted Source in the journal Scientific Reports – Gaultier and team sought to determine if and how the gut microbiome plays a role in depression. First, the researchers analyzed the gut microbiome of mice before and after they were exposed to stress. “When you’re stressed, you increase your chance of being depressed, and that’s been known for a long, long time,” notes Gaultier. The team found that stress led to the loss of Lactobacillus in the rodents’ guts, and this led to the onset of depression-like symptoms. Further investigation revealed that levels of Lactobacillus in the gut influence levels of a blood metabolite called kynurenine, which previous studies have associated with the development of depression. In this study, when Lactobacillus levels in the mice were decreased, levels of kynurenine increased, and this led to the development of depression-like symptoms. “This is the most consistent change we’ve seen across different experiments and different settings we call microbiome profiles,” says study co-author Ioana Marin, also of the Center for Brain Immunology and Glia. “This is a consistent change. We see Lactobacillus levels correlate directly with the behavior of these mice.” Lactobacillus supplementation reversed depression-like symptoms Next, the researchers supplemented the diets of the stressed mice with a strain of Lactobacillus called Lactobacillus reuteri for 3 weeks. Not only were the rodents’ Lactobacillus levels replenished as a result, but their depression-like symptoms were also reversed. These findings indicate that including Lactobacillus in the diet has the potential to treat depression by increasing kynurenine levels, though the researchers caution that much more research is needed to confirm this theory. “There has been some work in humans and quite a bit in animal models talking about how this metabolite, kynurenine, can influence behavior,” notes Marin. “It’s something produced with inflammation that we know is connected with depression. But the question still remains: How? How does this molecule affect the brain? What are the processes? This is the road we want to take.” In the meantime, the researchers say that there is no harm in patients with depression including yogurt in their diet. However, they stress that these individuals should not discontinue any medications without talking to their doctors.

Comments

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...